/PRNewswire/ Chemomab Therapeutics, Ltd. (Nasdaq: CMMB), a clinical-stage biotechnology company focused on the discovery and development of innovative.
Chemomab Therapeutics Appoints Jill M. Quigley, JD, to Its Board of Directors - read this article along with other careers information, tips and advice on BioSpace